Company intelligence / Profile preview

Hainan Yingda Runze Pharmaceutical

Haikou, Hainan, China

Ownership: Private
Development stage: Other

Overview

Hainan Yingda Runze Pharmaceutical is a China-based pharmaceutical company located in the Haikou National High-Tech Industrial Development Zone. The company specializes in the research, development, production, and sales of chemical drug preparations, with a focus on anti-infectives, gastrointestinal medications, and cardiovascular treatments. It operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to produce various dosage forms, including tablets and capsules. The company serves the domestic Chinese market by providing high-quality generic medications and essential healthcare products.

Therapeutic areas: Infectious DiseasesGastroenterologyCardiovascular
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Hainan Yingda Runze Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hainan Yingda Runze Pharmaceutical.

Explore the full profile